These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16923424)

  • 1. Temporal trends and drug exposures in pulmonary hypertension: an American experience.
    Walker AM; Langleben D; Korelitz JJ; Rich S; Rubin LJ; Strom BL; Gonin R; Keast S; Badesch D; Barst RJ; Bourge RC; Channick R; Frost A; Gaine S; McGoon M; McLaughlin V; Murali S; Oudiz RJ; Robbins IM; Tapson V; Abenhaim L; Constantine G
    Am Heart J; 2006 Sep; 152(3):521-6. PubMed ID: 16923424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iatrogenic pulmonary artery hypertension].
    Weitzenblum E; Kessler R; Chaouat A
    Rev Mal Respir; 1996; 13(2):133-9. PubMed ID: 8711232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminorex, dexfenfluramine, and primary pulmonary hypertension.
    Kramer MS; Lane DA
    J Clin Epidemiol; 1998 Apr; 51(4):361-4. PubMed ID: 9539893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anorexigen-related cardiopulmonary toxicity.
    Gross SB; Lepor NE
    Rev Cardiovasc Med; 2000; 1(2):80-9, 102. PubMed ID: 12457145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic pulmonary hypertension of vascular origin, plexogenic pulmonary arteriopathy and the appetite depressant aminorex: addenda to an epidemic].
    Gurtner HP
    Schweiz Med Wochenschr; 1985 Jun; 115(23):782-9contd. PubMed ID: 4023670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Appetite depressants and pulmonary hypertension].
    Hellermann J; Salomon F
    Ther Umsch; 1998 Sep; 55(9):548-50. PubMed ID: 9789468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminorex and pulmonary hypertension. A review.
    Gurtner HP
    Cor Vasa; 1985; 27(2-3):160-71. PubMed ID: 3928246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension associated with benfluorex exposure.
    Savale L; Chaumais MC; Cottin V; Bergot E; Frachon I; Prevot G; Pison C; Dromer C; Poubeau P; Lamblin N; Habib G; Reynaud-Gaubert M; Bourdin A; Sanchez O; Tubert-Bitter P; Jaïs X; Montani D; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2012 Nov; 40(5):1164-72. PubMed ID: 22523367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter?
    Gurtner HP
    Bull Eur Physiopathol Respir; 1979; 15(5):897-923. PubMed ID: 389330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.
    Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G
    Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appetite-suppressant drugs and primary pulmonary hypertension.
    Fishman AP
    N Engl J Med; 1997 Feb; 336(7):511; author reply 512-3. PubMed ID: 9019650
    [No Abstract]   [Full Text] [Related]  

  • 12. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.
    Rich S; Rubin L; Walker AM; Schneeweiss S; Abenhaim L
    Chest; 2000 Mar; 117(3):870-4. PubMed ID: 10713017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.
    Archer SL; Djaballah K; Humbert M; Weir KE; Fartoukh M; Dall'ava-Santucci J; Mercier JC; Simonneau G; Dinh-Xuan AT
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1061-7. PubMed ID: 9769261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary pulmonary hypertension: follow-up of patients with and without anorectic drug intake.
    Mlczoch J; Probst P; Szeless S; Kaindl F
    Cor Vasa; 1980; 22(4):251-7. PubMed ID: 7449394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension.
    Tuder RM; Radisavljevic Z; Shroyer KR; Polak JM; Voelkel NF
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1999-2001. PubMed ID: 9847298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term course of primary vascular pulmonary hypertension with and without intake of appetite depressants].
    Voss H; Feigel H; Bücking J
    Z Kardiol; 1983 Apr; 72(4):215-21. PubMed ID: 6868739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug induced pulmonary hypertension].
    Sato N; Nakanishi N
    Nihon Rinsho; 2001 Jun; 59(6):1197-202. PubMed ID: 11411136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure.
    Barst RJ; Abenhaim L
    Heart; 2004 Jul; 90(7):e42. PubMed ID: 15201268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension in a patient with Cowden syndrome and anorexigen exposure.
    Natali D; Girerd B; Montani D; Soubrier F; Simonneau G; Humbert M; Sitbon O
    Chest; 2011 Oct; 140(4):1066-1068. PubMed ID: 21972386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: The epidemic of primary pulmonary hypertension in Europe.
    Lüthy E
    Pathol Microbiol (Basel); 1975; 43(2-O):246-7. PubMed ID: 1228586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.